HHG & Company’s Allergan plc AGN Stock Holding History

HHG & Company’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-883	Closed	-$227K	–	209
2014 Q4	$227K	Buy	883 +39	+5%	+$9.75K	0.05%	185
2014 Q3	$204K	Buy	+844	New	+$189K	0.07%	152

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

HHG & Company's AGN Position: Q1 2015 in Review

HHG & Company sold out of Allergan plc (AGN) in Q1 2015, closing a stake of 883 shares — an estimated $227K sold.

HHG & Company first reported a position in AGN in Q3 2014 and held it in 2 quarters. The position peaked at $227K in Q4 2014. 1,089 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

HHG & Company reported no remaining Allergan plc position as of Q1 2015 after selling out during the quarter.
HHG & Company sold 883 Allergan plc shares in Q1 2015, an estimated $227K.
HHG & Company first reported a position in Allergan plc in Q3 2014 and held it in 2 quarters.
HHG & Company's Allergan plc position peaked at $227K in Q4 2014.
1,089 funds tracked by Wall St. Rank held Allergan plc as of Q1 2015.

Based on HHG & Company's 13F filing for Q1 2015, filed 27 Apr 2015.